SignalChem Lifesciences Corporation
$600,000.00
National Research Council Canada | Conseil national de recherches Canada
Eureka/Eurostar
EF 2020-2021
Canada
EUREKA Project 15211 EHAV-19 - Engineering of high affinity ACE2 variants as a treatment for Covid-19 with Austrian partner Innophore GmbH.